VEMURAFENIB Home | Cancer | Solid Tumors | VEMURAFENIB
VEMURAFENIB Tablets Description Composition Dosage Indications ZELBORAF (vemurafenib) is a kinase inhibitor available as 240 mg tablets for oral use. Tablets of ZELBORAF are for oral administration. Each tablet contains 240 mg of vemurafenib. 281 The inactive ingredients of ZELBORAF are: Tablet core: hypromellose acetate succinate, croscarmellose 282 sodium, colloidal silicon dioxide, magnesium stearate, and hydroxypropyl cellulose. Coating: pinkish 283 white: poly (vinyl alcohol), titanium dioxide, polyethylene glycol 3350, talc, and iron oxide red.
Copyright © 2024 ImpoMed
Convert web pages and HTML files to PDF in your applications with the Pdfcrowd HTML to PDF API
Printed with Pdfcrowd.com